Two Years of Clinical Experience with Biologic Agents for Psoriasis: Latest Study Findings and Individual Physician Experience

A supplement to Skin & Allergy News.
This supplement was jointly sponsored by the Elsevier Office of Continuing Medical Education (EOCME) and Skin & Allergy News. It was supported by an unrestricted educational grant from Genentech.
The articles in this supplement are based on presentations made at a continuing medical education program held February 18-22, 2005, in New Orleans, La.

•Topic Highlights
•Faculty/Faculty Disclosure Statement

To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 15.

• Topic Highlights
• Accreditation
• Target Audience
• Educational Needs
• Learning Objectives
• Faculty Disclosures
• Unapproved/Off-Label Use Disclosure

Topic Highlights

• Introduction
• Biologic Agents for Psoriasis: Latest Study Findings
• New Biologic Agents on the Horizon
• Individual Physical Experience and Insights
• Summary
• References
• CME Post Test & Evaluation
Faculty/Faculty Disclosure Statement

Tiffani K. Hamilton, MD
Private Practice
Atlanta Dermatology, Vein & Research Center, LLC
Atlanta, Ga.
Dr. Hamilton has received grants/research support from Abbott Laboratories, Amgen Inc., Biogen Idec Inc., Centocor, Inc., Genentech, Inc., Immunex Corp., Synta Pharmaceuticals Corp., and Vertex Pharmaceuticals Incorporated. She is consultant to Amgen, Dermik Laboratories, and Genentech. Dr. Hamilton is also on the Speaker's Bureau at Amgen, Biogen, Centocor, Dermik, and Genentech.

Paul S. Yamauchi, MD, PhD
Private Practice
Dermatology Institute and Skin Center
Clinical Research Specialists
Santa Monica, Calif.
Dr. Yamauchi has received grant/research support from Abbott, Amgen, Biogen, Genentech, and Serono S.A. He is a consultant to and on the Speaker's Bureau at Amgen, Biogen, and Genentech.

Copyright © 2005 by International Medical News Group

---